follow.it gives you an easy way to subscribe to Neuro-Oncology: The Podcast's news feed! Click on Follow below and we deliver the updates you want via email, phone or you can read them here on the website on your own news page.
You can also unsubscribe anytime painlessly. You can even combine feeds from Neuro-Oncology: The Podcast with other site's feeds!
Title: Neuro-Oncology: The Podcast
Is this your feed? Claim it!
Podcast Host and Interviewee:
Host – Elham (El) Rahimy, MD
Interviewee: Jonathan Yang, MD PhD
Podcast Description:
These two sessions explore leptomeningeal and parenchymal metastases from the view point of radiation oncology. We delve into the clinical approach and integration of recent trials in the decision of radiation regimens/modalities...
Podcast Host and Interviewee:
Host – Elham (El) Rahimy, MD
Interviewee: Jonathan Yang, MD PhD
Podcast Description:
These two sessions explore leptomeningeal and parenchymal metastases from the view point of radiation oncology. We delve into the clinical approach and integration of recent trials in the decision of radiation regimens/mo...
In this episode of Author Interviews from the Society for Neuro-Oncology journals, Dr. Jiasen He (UT MD Anderson Cancer Center) speaks with Dr Stephen C. Mack and Dr. Kelsey C. Bertrand from St. Jude Children's Research Hospital about their recently published article in Neuro-Oncology titled 'Nuclear export as a therapeutic vulnerability in ZFTA-RELA ependymoma
Author...
Podcast Host: Ramya Tadipatri
Podcast Interviewee: Na Tosha Gatson
Podcast Description: Dr. Ramya Tadipatri interviews Dr. Na Tosha Gatson on the evolving landscape of leptomeningeal disease with a focus on liquid biopsy.
Podcast Host and Interviewee: Shahad Abdulsahib, PhD Graduate, UT Health San Antonio
Podcast Description: Shahad Abdulsahib discusses a landmark preclinical study evaluating Synthetic Super-Enhancer-based gene therapy for glioblastoma, published in Nature in April 2026, and the rapid translation of these findings into the first-in-human Phase 1/2 ADePT clinical trial w...